Surgical Periodontal Treatment
Resective Surgery · Regenerative Procedures · Mucogingival Surgery · Crown Lengthening
TL;DR
Surgical periodontal treatment — Phase II of the four-phase periodontal treatment sequence — encompasses all operative procedures that access the root surfaces, underlying bone, and surrounding soft tissues through surgically elevated flaps to achieve outcomes that non-surgical treatment (NSPT) cannot: thorough debridement in anatomically inaccessible pockets, elimination of osseous defects, restoration of adequate keratinised gingiva, root coverage, and creation of an environment compatible with long-term health maintenance and restorative dentistry. Surgery is never the first intervention — NSPT must be completed and re-evaluated before any surgical decision is made. The goal of periodontal surgery is not to cure the disease but to create an anatomical environment (pocket elimination or reduction, adequate tissue architecture, accessible root surfaces) that the patient and clinician can maintain through supportive periodontal therapy (SPT).
- Resective vs. regenerative surgery — the central surgical decision: Resective surgery (osseous surgery, apically repositioned flap, gingivectomy) eliminates pockets by removing the tissue (gingiva and/or bone) that forms the pocket walls — the result is a reduced pocket depth at the cost of tissue volume (recession, reduced alveolar bone height). Regenerative surgery (GTR, bone grafts, EMD) attempts to rebuild what has been destroyed — restoring bone, PDL, and cementum in infrabony defects — at the cost of greater technical complexity and less predictability. The choice is determined by defect morphology: three-walled infrabony defects (most regenerative potential) → regenerative approach; horizontal bone loss with suprabony pockets → resective approach; furcation Class II mandibular → GTR or root resection; furcation Class III → likely extraction or root resection in specific anatomical conditions.
- Guided tissue regeneration exploits the biological principle that cell type determines tissue type: GTR is based on Melcher’s concept (1976) that the nature of the cells that first populate a periodontal wound determines the type of tissue that regenerates there. If epithelial cells populate the root surface first (as they do in uncontrolled wound healing — epithelium migrates 0.5–2 mm/day, far faster than PDL progenitor cells), a long junctional epithelium forms rather than new cementum and PDL. GTR physically excludes epithelium and gingival connective tissue from the infrabony defect using a resorbable or non-resorbable membrane barrier, allowing the slower-migrating PDL progenitor cells (from the PDL space and bone marrow) to populate the root surface and regenerate the attachment apparatus. The evidence base (Cochrane 2002 — Murphy & Gunsolley; multiple systematic reviews) confirms GTR produces significantly more CAL gain and bone fill than flap debridement alone for contained infrabony defects.
- Bone graft classification by origin determines immunogenicity and resorption rate: Autografts (patient’s own bone — gold standard, osteogenic + osteoconductive + osteoinductive, zero immunogenicity) are limited by donor site morbidity; allografts (cadaveric human bone — DFDBA, FDBA; osteoconductive and potentially osteoinductive; commercially available, no donor site morbidity; antigenicity eliminated by processing); xenografts (bovine, porcine, equine bone — bio-oss; osteoconductive; low resorption rate; excellent space maintenance; most widely used in clinical practice); and alloplasts (synthetic — β-TCP, hydroxyapatite, bioactive glass; osteoconductive only; no disease transmission risk; variable resorption rates). The combination of bone graft + GTR membrane (combined approach) produces superior outcomes to either alone for contained three-walled and deep two-walled infrabony defects.
- Connective tissue grafts are the gold standard for root coverage: For Miller Class I and II gingival recession (where the inter-proximal bone and soft tissue are intact), the subepithelial connective tissue graft (SCTG) combined with a coronally advanced flap (CAF) produces the most predictable and aesthetically superior root coverage outcomes — better colour match, greater tissue thickness, and higher complete root coverage rates than free gingival grafts (FGG) or CAF alone. The SCTG is harvested from the palate (typically premolar-to-molar region), and provides both the coverage graft and a biological stimulus for revascularisation. Multiple systematic reviews (Chambrone et al., Cochrane 2009) confirm CTG + CAF as the highest evidence-base root coverage technique.
- Crown lengthening surgery has two clinically distinct indications that require different procedures: Functional crown lengthening (for restorative margin placement) requires both soft tissue repositioning (apical flap) AND osseous surgery (removal of supporting bone) to establish adequate space between the alveolar bone crest and the proposed margin — typically ≥3 mm of tooth structure must be exposed above the new bone crest to allow the STA (2 mm) plus at least 1 mm of sound tooth structure above the margin. Aesthetic crown lengthening (for a “gummy smile” due to delayed passive eruption) may require only gingivectomy if the bone is at a normal level relative to the CEJ — if the bone is also coronal (short clinical crown with normal alveolar position), osseous surgery is required in addition. Failure to perform the osseous component when necessary results in creeping reattachment — the gingiva recoronal-ises and the clinical crown shortens again within months.
Key Facts
What Is Surgical Periodontal Treatment?
Surgical periodontal treatment is Phase II of the four-phase periodontal treatment sequence: Phase I (systemic phase — risk factor modification, medical management); Phase II (cause-related therapy — NSPT); Phase III (corrective phase — surgery); Phase IV (maintenance phase — SPT). This sequence is strictly observed: surgery is performed only after Phase II has been completed, re-evaluated, and found to be insufficient to achieve disease control. Surgery in a non-compliant patient, in a patient with uncontrolled systemic risk factors, or before thorough NSPT will not produce results superior to NSPT alone and may produce worse outcomes.
The rationale for surgical treatment over NSPT is access: surgical flap reflection provides direct visual and instrumental access to root surfaces, furcation entrances, and osseous defects that are anatomically inaccessible to subgingival instruments without raising a flap. In pockets ≥7 mm, systematic studies confirm that subgingival debridement without flap access leaves residual deposits on root surfaces in the majority of cases — deposits that maintain the microbial community responsible for continued attachment loss. Flap surgery eliminates this access limitation, but it does not change the requirement for effective post-surgical oral hygiene maintenance — the same plaque community that caused the original disease will cause disease recurrence if the patient’s biofilm control is inadequate after surgery.
Why It Matters
Surgical periodontal treatment integrates anatomy, wound healing biology, biomaterial science, and restorative dentistry into clinical decision-making. Board examinations test: the indications for surgery vs. NSPT; GTR membrane types and the biological principle behind GTR; bone graft classification and properties; Miller classification and root coverage predictability; crown lengthening — when osseous surgery is required vs. gingivectomy alone; and the difference between repair (long JE) and regeneration (new cementum + PDL + bone).
Clinical Relevance
- The periodontal surgical outcome depends almost entirely on the quality of NSPT performed beforehand: Surgery performed through inflamed, oedematous tissue produces inaccurate bone contour assessment, excessive haemorrhage obscuring the operative field, and poor flap adaptation at the time of suturing. The pre-surgical tissue must be in the best achievable state of health — all achievable plaque and calculus removed, BOP minimised through patient oral hygiene improvement, and gingival oedema resolved — before flap elevation. “Pre-surgical hygiene phase” is not just Phase I/II compliance assessment; it is a biological prerequisite for accurate surgical planning and predictable healing.
- The osseous defect morphology determines the surgical approach more than the pocket depth: A 7 mm pocket on the mesial surface of a lower molar adjacent to a deep three-walled infrabony defect has fundamentally different treatment requirements from a 7 mm pocket on the buccal surface of the same tooth where horizontal bone loss has produced a suprabony pocket. The former is a regenerative opportunity — with GTR and/or bone graft producing new attachment; the latter requires resective surgery or NSPT alone. Pre-surgical radiographic and clinical assessment (bone sounding, probing pattern, CBCT where indicated) must define the defect morphology to allow appropriate procedure selection.
- Pocket elimination surgery reduces pocket depth permanently — but at the cost of permanent recession: Resective surgery (apically repositioned flap with osseous surgery) produces pocket elimination by relocating the gingival margin to the level of the alveolar bone crest, eliminating the soft tissue pocket wall and removing any irregular bone to create a flat, ostectomy-corrected bone contour. The result is genuinely reduced pocket depth and easy plaque access — but the gingival recession is permanent and aesthetically significant in anterior teeth. Resective surgery is therefore contraindicated in the anterior maxilla of patients with an aesthetic concern or a high smile line, and in teeth where recession would expose the crown margin or furcation. The decision to perform resective surgery in the aesthetic zone requires detailed patient counselling about the permanent aesthetic consequences.
- SPT after surgery is not optional — it is the determinant of long-term success: Multiple long-term clinical studies (Nyman et al. 1975; Ramfjord maintenance studies; Axelsson & Lindhe 1981 — showing that without regular professional maintenance, even successfully treated periodontitis patients relapse within 2–3 years) confirm that the clinical gains of periodontal surgery are maintained only in patients who comply with regular supportive periodontal therapy. Surgery performed in a non-SPT-compliant patient produces a temporary improvement in clinical parameters followed by disease recurrence. Before surgery is offered, the clinician must honestly assess the patient’s compliance history and ability to maintain the post-surgical result — surgery in a non-compliant patient is an ethically questionable commitment of surgical resources.
Indications for Surgical Periodontal Treatment
Surgical treatment is indicated when NSPT has been completed and re-evaluated, and the re-evaluation findings demonstrate that disease control cannot be maintained non-surgically. Specific indications include:
- Residual pockets ≥6 mm with BOP after thorough NSPT in a compliant patient with controlled risk factors — particularly on proximal surfaces of posterior teeth where NSPT access is most limited
- Furcation Class II or III involvement where NSPT cannot provide thorough debridement and cannot be maintained by the patient
- Infrabony defects with ≥3 mm of vertical component (≥3-walled or deep 2-walled) where regenerative procedures may produce clinically significant attachment gain
- Need for crown lengthening before fixed restorative dentistry where biologic width is inadequate for planned margin placement
- Mucogingival deficiencies requiring keratinised tissue augmentation (inadequate attached gingiva at planned restoration margins; aesthetic recession correction) where patient is committed to long-term maintenance
- Stage IV periodontitis requiring combined periodontal-prosthetic rehabilitation with surgical access as a component
When to Refer — Surgical Decision Pathway
Resective Periodontal Surgery
Resective surgery eliminates periodontal pockets by removing the tissue forming the pocket walls — either the soft tissue wall (gingivectomy), the hard tissue wall (osseous surgery), or both (apically repositioned flap with osseous surgery). The goal is pocket elimination — creating a sulcus depth that the patient can maintain with effective oral hygiene — at the unavoidable cost of permanent tissue loss (recession, reduced alveolar bone height). Resective surgery is most appropriate where regeneration is not biologically indicated (shallow infrabony defects, horizontal bone loss, suprabony pockets) and where aesthetics are not a primary concern.
Osseous Surgery
Osseous surgery (os = bone) modifies the morphology of the alveolar bone to eliminate the irregular bone contours that result from periodontitis-related bone loss and to create a physiological bone architecture that is compatible with the creation and maintenance of a reduced but healthy sulcus. Two concepts underpin osseous surgery technique:
Positive architecture (physiological bone form) describes a bone contour where the interproximal bone is coronal to the buccal and lingual bone — a natural scallop that follows the arc of the CEJ and provides the architecture for a physiological gingival form. Negative architecture (reverse architecture) describes the situation created by periodontitis where interproximal craters and bony walls create bone that is more coronal proximally than at the buccal/lingual — the reverse of the physiological pattern. Negative architecture prevents gingival adaptation after flap closure and is associated with residual pockets after surgery.
Osteoplasty refers to reshaping bone that is not directly supporting teeth — removing non-supportive bone to achieve physiological form without reducing the bone support available to the teeth. Ostectomy refers to the removal of bone that is supporting teeth — reducing the crestal bone height to eliminate infrabony defect walls and create positive architecture. Ostectomy therefore reduces attachment level as well as pocket depth; it is the source of the permanent attachment loss associated with resective surgery and must not be performed casually or excessively.
Gingivectomy
Gingivectomy is the excision of the pocket wall by an external bevel incision that removes the free and attached gingival tissue forming the lateral wall of the pocket above the bone crest. It is indicated for the elimination of suprabony pockets where the base of the pocket is coronal to the alveolar bone crest — because in these pockets, excision of the pocket wall above the bone will leave a sulcus with a base on sound attached gingiva or bone crest without exposing the bone itself. Gingivectomy is also the primary treatment for drug-induced gingival overgrowth (DIGO) in phenytoin, ciclosporin, and calcium channel blocker therapy, where the enlarged gingiva typically forms suprabony pseudopockets.
Gingivectomy is contraindicated where: the pocket base is at or apical to the bone crest (infrabony pocket — gingivectomy would expose bare bone); the available attached gingiva is insufficient (removing it would leave the gingival margin on alveolar mucosa); osseous surgery is simultaneously required (an apically repositioned flap is preferred); or adequate access to the operative site cannot be achieved without a flap.
Furcation Involvement — Surgical Management
| Furcation Class | Description | Preferred Surgical Approach | Prognosis |
|---|---|---|---|
| Class I | Horizontal probe penetration <3 mm into furcation; bone level approximately equal at furcation and adjacent areas | NSPT usually sufficient; if surgery required: open flap debridement (modified Widman) with furcation access | Good — responds well to NSPT; surgical outcome predictable |
| Class II | Horizontal probe penetration ≥3 mm but NOT through-and-through; furcation dome of bone still present | GTR with resorbable membrane ± bone graft (mandibular buccal Class II — best evidence for regeneration); furcation plasty (odontoplasty of furcation entrance to improve access); or root resection (maxillary molars — remove one root) | Guarded — regeneration produces variable outcomes; maxillary Class II furcations are less predictable than mandibular buccal |
| Class III | Through-and-through furcation; probe passes completely between roots; no remaining furcation bone dome | Extraction (most cases — Class III is a significant prognostic factor); root resection / hemisection if individual root quality is good; tunnelling (mandibular molars — allows patient to brush through furcation with interproximal brush) | Poor — extraction usually indicated for long-term disease control; tunnelling requires meticulous maintenance; root resection requires endodontic treatment of remaining root(s) |
Regenerative Periodontal Surgery
Regenerative periodontal surgery aims to restore the components of the periodontium that have been destroyed by disease — not merely to create a healthier environment, but to rebuild new cementum on the root surface, new PDL fibres inserting into that cementum, and new alveolar bone adjacent to the restored PDL. True regeneration is distinguished from repair (healing by long junctional epithelium — technically filling the defect but without a functional PDL attachment) by histological examination and, in clinical practice, by the pattern of attachment gain. The biological basis for regeneration is the presence of progenitor cells in the PDL and bone marrow that, when given appropriate scaffolding, space maintenance, and biological stimulation, can reform all three attachment tissues simultaneously.
Guided Tissue Regeneration (GTR)
GTR is based on Melcher’s concept (1976) and Nyman, Lindhe, and colleagues’ landmark clinical demonstration (1982) that a membrane barrier placed between the gingival flap and the root surface could exclude epithelial cells and gingival fibroblasts from the healing wound, allowing PDL progenitor cells to populate the root surface and regenerate new attachment. The technique involves: (1) thorough root surface preparation (complete debridement of the defect under direct vision); (2) root conditioning if used (EDTA 24% or tetracycline root surface conditioning — opens dentinal tubules and exposes collagen, creating a more receptive surface for progenitor cell attachment; evidence for benefit is mixed); (3) placement of the membrane barrier to cover the defect and extend 2–3 mm onto the surrounding sound bone; (4) primary closure of the gingival flap over the membrane without tension (tension-free primary closure is the non-negotiable requirement for GTR success — membrane exposure causes contamination and complete procedural failure); (5) post-operative chlorhexidine maintenance.
| Feature | Non-Resorbable Membrane (e-PTFE) | Resorbable Membrane (Collagen — Bio-Gide) |
|---|---|---|
| Material | Expanded polytetrafluoroethylene; titanium-reinforced for large defects | Porcine type I/III collagen bilayer; resorbable by collagenase activity |
| Second surgery | Required — membrane must be removed at 6–8 weeks (titanium-reinforced: 6–9 months) | Not required — degrades in situ over 4–24 weeks |
| Space maintenance | Excellent — does not collapse; titanium frame maintains space in large defects without bone graft | Requires bone graft for space maintenance in most defects (collagen membranes are compressible and will collapse without support) |
| Outcomes | Gold standard evidence; superior space maintenance; most predictable for large/complex defects | Equivalent outcomes to e-PTFE in ≤3-wall defects when used with bone graft; preferred in clinical practice due to no second surgery |
| Risk of premature exposure | High (2 weeks exposure → membrane must be removed immediately; contaminated membrane is colonised by pathogens and drives infection) | Lower clinical impact of exposure (exposed collagen is partly resorbable, though outcomes are reduced) |
| Clinical use trend | Reserved for complex large defects and bone augmentation (GBR) where space maintenance is critical | Predominant choice for intrabony defects in contemporary periodontal practice; combined with Bio-Oss xenograft |
Bone Grafts in Periodontal Regeneration
Bone grafts fill the infrabony defect space, provide a scaffold for new bone ingrowth, and — for grafts with osteoinductive properties — actively stimulate new bone formation. Three biological mechanisms are relevant: osteogenesis (new bone formed directly by viable osteoblasts in the graft — autografts only); osteoinduction (stimulation of host progenitor cells to differentiate into osteoblasts by bone morphogenetic proteins (BMPs) and other growth factors in the graft — autografts, DFDBA); and osteoconduction (passive scaffold providing a physical template for ingrowth of blood vessels and osteoblasts from the surrounding host bone — all graft types).
| Graft Type | Origin | Mechanisms | Resorption | Clinical Notes |
|---|---|---|---|---|
| Autograft | Patient’s own bone (intraoral: tuberosity, exostoses, healing sockets; extraoral: iliac crest, tibia) | Osteogenesis + Osteoinduction + Osteoconduction — gold standard | Variable; depends on cortical vs. cancellous composition | No immunogenicity; best biological potential; limited by donor site morbidity and volume available; intraoral sources most convenient; extraoral sources (iliac) provide large volumes for severe defects |
| Allograft — DFDBA (demineralised freeze-dried bone allograft) | Cadaveric human bone; demineralised to expose BMPs; freeze-dried and irradiated for sterilisation | Osteoinduction + Osteoconduction (BMPs exposed by demineralisation stimulate progenitor differentiation) | Variable; faster than FDBA | No donor site morbidity; commercially available; osteoinductive potential varies between batches (BMP content variable); disease transmission risk extremely low but not zero; processed under stringent standards (AATB regulations) |
| Allograft — FDBA (freeze-dried bone allograft) | Cadaveric human bone; not demineralised; freeze-dried | Osteoconduction primarily (mineral intact; BMPs not exposed) | Slower than DFDBA; provides longer-lasting scaffold | Good space maintenance due to slow resorption; less osteoinductive than DFDBA; preferred where long-term scaffold maintenance is more important than immediate osteoinduction |
| Xenograft — Bovine (Bio-Oss) | Bovine bone (deproteinised by heating and chemicals — removes organic components, retains mineral scaffold) | Osteoconduction only — no cells, no growth factors; inorganic hydroxyapatite scaffold | Very slow — Bio-Oss particles may persist for 3–5+ years; excellent long-term volume maintenance | Most widely used graft in contemporary periodontal and implant surgery; consistent quality; volume stable; excellent for socket preservation and GBR; combined with Bio-Gide collagen membrane (standard GTR/GBR combination). No osteogenic or osteoinductive capacity — purely scaffold. |
| Alloplast (synthetic) | Synthetic: β-tricalcium phosphate (β-TCP), hydroxyapatite (HA), bioactive glass, calcium sulphate | Osteoconduction only | β-TCP: resorbable (months); HA: slowly resorbable or permanent; bioactive glass: variable | No disease transmission risk; unlimited supply; consistent properties; β-TCP used as graft in combination procedures; HA can be mixed with DFDBA to extend volume; variable evidence base for periodontal applications |
Enamel Matrix Derivatives (EMD / Emdogain)
Enamel matrix derivatives (EMD) are a porcine extract of the enamel matrix proteins produced during embryonic root development — principally amelogenin (>90% by weight) with smaller amounts of ameloblastin, enamelin, and other enamel proteins. The biological rationale is that these proteins, when applied to the denuded root surface, recapitulate the embryonic conditions under which the periodontium originally formed — stimulating the same cellular events (cementoblast activation, PDL progenitor proliferation and differentiation, osteoblast recruitment) that produced the original attachment apparatus. The commercial product (Emdogain) is a viscous gel applied to the root surface immediately after root conditioning with 24% EDTA (which removes the smear layer and exposes dentinal collagen, improving protein adsorption to the root surface) and before flap closure.
The Cochrane systematic review (Esposito et al. 2009) found that EMD as an adjunct to flap surgery produced significantly greater CAL gain (mean difference ~1.1 mm) and probing depth reduction compared with flap surgery alone, with outcomes similar to GTR with resorbable membranes. The advantage of EMD over GTR is technical simplicity: no membrane placement, no risk of membrane exposure, no second surgery — the protein is a liquid applied to the root surface before closure. EMD is most effective in deep, contained infrabony defects (≥3 mm vertical component, ≥2 walls remaining) and is frequently combined with bone grafts (Bio-Oss + Emdogain) for optimal results in deep complex defects.
Mucogingival and Periodontal Plastic Surgery
Mucogingival surgery — now termed periodontal plastic surgery — encompasses all surgical procedures performed to correct deficiencies in the dimensions, contour, and relationships of the gingival tissues and alveolar mucosa. The most common indications are: gingival recession correction (root coverage), keratinised gingiva augmentation, papilla reconstruction, and peri-implant soft tissue management. The nomenclature reflects a shift from purely functional objectives (enough keratinised tissue to resist trauma) to aesthetic and functional integration with the entire dento-facial unit.
Free Gingival Graft (FGG)
The free gingival graft was the first described technique for keratinised tissue augmentation (Bjorn 1963; Sullivan & Atkins 1968). A thin (1.0–1.5 mm thickness) sheet of gingiva including epithelium and a thin layer of lamina propria is harvested from the palate and sutured directly onto a prepared recipient bed on the alveolar mucosa apical to the recession site. The graft epithelium initially undergoes complete necrosis (the palatal epithelium does not survive transplantation — its blood supply is severed at harvest); the connective tissue layer survives by plasmatic imbibition (passive diffusion of nutrients from the recipient bed) for the first 48–72 hours before revascularisation by inosculation (ingrowth of new vessels from the recipient bed into the graft). The re-epithelialisation of the graft surface occurs from the graft’s surviving connective tissue cells, creating a keratinised epithelium that mirrors the palatal donor site character — hence the whitish, opaque appearance of FGGs, which does not colour-match the surrounding mucosa. FGGs are excellent for keratinised tissue augmentation at implant sites and at teeth with minimal attached gingiva and no aesthetic demand; they are less suitable for root coverage where colour match is important.
Connective Tissue Graft (CTG / SCTG)
The subepithelial connective tissue graft (SCTG), developed by Langer and Langer (1985) and refined by Raetzke (1985) and Allen (1994), is the current gold standard technique for root coverage. A split-thickness incision on the palate creates a trap-door flap, and the underlying connective tissue is harvested — the palatal epithelium remains in place over the donor site, allowing primary closure of the palatal wound (superior donor site healing compared with FGG). The connective tissue graft is then placed over the denuded root surface and sutured under a coronally advanced flap (CAF) on the recipient site. The graft is entirely covered by the CAF — it receives blood supply from both the recipient bed beneath it (plasmatic imbibition → revascularisation) and from the overlying CAF (direct vessel ingrowth). This dual blood supply produces superior graft survival and a superior aesthetic result: the CTG induces keratinisation of the overlying mucosa while maintaining a colour match with the surrounding tissue (because the overlying CAF provides the surface epithelium, which matches the adjacent mucosa). Systematic reviews confirm SCTG + CAF produces higher complete root coverage rates and better aesthetic outcomes than any other single technique for Miller Class I and II recession.
Coronally Advanced Flap (CAF)
The coronally advanced flap (CAF) alone (without a graft) can achieve root coverage in specific situations: Miller Class I recession, wide recession width (>3 mm — sufficient tissue for tension-free coronal advancement), and thick gingival biotype (thick tissue provides better vascularisation and resistance to recession recurrence post-operatively). When used alone, the CAF produces acceptable root coverage rates for single recession defects with adequate tissue thickness, but inferior outcomes compared with CAF + CTG in thin-biotype patients or where tissue volume augmentation is required. The CAF procedure: (1) horizontal incision at the CEJ of the affected tooth; (2) split-full-split thickness elevation (split-thickness at the papillae to preserve their volume; full-thickness over the recession area; split-thickness apically in the alveolar mucosa to allow tension-free advancement); (3) periosteal scoring apically to allow coronal advancement; (4) sling suture to stabilise the flap at the CEJ level; (5) interrupted or mattress sutures at releasing incisions.
Miller Classification and Root Coverage Predictability
The Miller classification (1985) stratifies gingival recession defects by the amount of soft and hard tissue present at the interdental area, which determines whether complete root coverage is achievable:
- Miller Class I: Recession not extending to or beyond the MGJ; no loss of interdental bone or soft tissue. Complete root coverage is predictably achievable with CTG + CAF or CAF alone.
- Miller Class II: Recession extending to or beyond the MGJ; no loss of interdental bone or soft tissue. Complete root coverage is predictably achievable with CTG + CAF — the only difference from Class I is the greater extent of recession apically, which requires a more extensive CAF.
- Miller Class III: Recession to or beyond the MGJ WITH loss of interdental bone or soft tissue OR malposition of the tooth. Only partial root coverage is expected — the interdental tissue loss limits how coronally the flap can be advanced. Surgery can improve appearance and reduce sensitivity but cannot achieve complete coverage.
- Miller Class IV: Severe interdental bone and soft tissue loss; tooth malposition. Root coverage not predictable — surgery is unlikely to achieve meaningful improvement in coverage; aesthetic management may be more appropriate than root coverage surgery.
Crown Lengthening Surgery
Crown lengthening is the surgical exposure of additional tooth structure — either to provide a sufficient clinical crown length for restoration placement without violating the biologic width (STA), or to improve the aesthetic appearance of a “gummy smile” due to delayed passive eruption. It is one of the most commonly performed periodontal surgical procedures and one with the most direct integration with restorative dentistry. Failure to perform crown lengthening when indicated — or failure to perform it correctly — produces either STA violation (chronic inflammation, bone loss, pocket formation at restoration margins) or recurrence of the short clinical crown appearance (creeping reattachment if osseous surgery was not performed).
| Indication | Objective | Procedure Required | Critical Measurement |
|---|---|---|---|
| Functional (restorative) | Create ≥3 mm of tooth structure above alveolar bone crest for margin placement without STA violation | Apically repositioned flap (ARF) + ostectomy/osteoplasty — BOTH soft tissue AND bone surgery are required. Gingivectomy alone is contraindicated (will recur) | Bone sounding pre-operatively: measure gingival margin to bone; calculate tooth structure exposed above bone post-op. Need: margin position + 2 mm STA + ≥0.5 mm above margin to provide “ferrule effect” |
| Aesthetic (delayed passive eruption) | Expose full anatomical crown; eliminate gingival excess coronal to CEJ; improve smile aesthetics | If bone at correct level (CEJ–bone ≥ 2 mm): gingivectomy alone is sufficient. If bone is also coronal to ideal position: ARF + ostectomy required to prevent recurrence | Pre-surgical bone sounding to determine whether bone is at normal position or also coronal. Normal position: bone crest 1–2 mm apical to CEJ. If bone is coronal: surgical crown lengthening with ostectomy required. |
| Subgingival fracture / caries margin | Expose fracture line or caries margin to allow restoration; confirm tooth restorability | ARF + ostectomy to position bone crest ≥3 mm apical to the most apical extent of the fracture/caries — only then is the restoration margin achievable without STA violation | Fracture must not extend below the osseous crest; subcrestal fractures with inadequate remaining tooth structure above bone preclude restoration even after crown lengthening → extraction indicated |
Supportive Periodontal Therapy (SPT)
Supportive periodontal therapy (SPT) — also called periodontal maintenance therapy (PMT) or Phase IV periodontal treatment — is the continuing care programme that maintains the outcomes achieved by active periodontal treatment (Phases I–III). It is not routine recall scaling; it is a structured, risk-based monitoring and intervention programme specifically designed for patients who have been diagnosed and treated for periodontitis. The fundamental evidence base for SPT (Axelsson & Lindhe 1981; Nyman et al. 1975) demonstrates that without regular professional intervention, periodontitis recurs in the majority of treated patients within 2–3 years — even in patients with good oral hygiene.
SPT appointments include: full periodontal assessment (PPD, BOP, plaque score, recession, furcation — compared with baseline and previous SPT records to detect progression); assessment of risk factors (smoking cessation status, glycaemic control); supragingival and subgingival debridement at all accessible sites (not full-mouth SRP — targeted instrumentation of sites with BOP, residual pockets, and plaque); OHI reinforcement; and radiographic monitoring at appropriate intervals (BPE-guided — annual for high BPE scores, 24-monthly for stable patients). The recall interval for SPT is risk-stratified: every 3 months for high-risk patients (Stage III/IV, Grade C, heavy smokers, poorly controlled diabetes, poor oral hygiene compliance); every 3–4 months for medium-risk; every 6 months for low-risk patients at least 2 years post-active treatment with stable attachment levels. Annual recall is not appropriate for treated periodontitis patients — the biology of plaque biofilm maturation and recolonisation of treated sites does not allow such long intervals without disease recurrence in periodontitis-susceptible individuals.
Clinical Considerations
- Photodynamic therapy as an adjunct to periodontal surgery shows insufficient evidence for routine recommendation: As with NSPT (see Non-Surgical Treatment article), aPDT has been investigated as an adjunct to surgical periodontal treatment. Results are inconsistent — some trials show modest additional PPD reductions (~0.3–0.4 mm), but effect sizes are small, study heterogeneity is high, and there is no systematic review-level evidence supporting routine aPDT adjunction to periodontal surgery. Its use in specialist practice may be appropriate for selected cases (antibiotic-resistant patients, refusal of systemic antibiotics) but it should not be promoted as a standard surgical adjunct based on current evidence.
- Tunnel preparation for Class III mandibular furcation involvement requires specific patient selection and commitment: The tunnelling procedure (open root planing of the furcation to create a through-and-through space accessible to interdental brushes) converts a Class III furcation from an untreatable niche into a maintainable space. It requires: sufficient root divergence to allow instrument passage; adequate furcation height (minimum 3 mm vertical room for brush passage); and patient absolute commitment to daily interdental brush use in the tunnel. Without this daily maintenance, root caries in the denuded furcation is almost inevitable — the exposed root dentine in the furcation is highly caries-susceptible, and the tunnel is an anaerobic niche that rapidly accumulates cariogenic biofilm. Fluoride varnish at every SPT appointment and high-fluoride toothpaste are adjuncts, not substitutes, for mechanical plaque control in tunnelled furcations.
- The palatal donor site requires specific post-operative management distinct from periodontal flap sites: The palatal connective tissue donor site heals by secondary intention — the palatal epithelium is reflected back over the donor area at closure (when the trap-door approach is used), but incomplete closure means the deep aspects of the donor site granulate from the periosteal surface upward. Post-operative instructions must warn patients that the palate will be the most painful area for the first 72 hours (more so than the recipient site, which is typically covered by a periodontal dressing); a palatal stent (vacuum-formed clear matrix fabricated pre-operatively over a study model) dramatically reduces post-operative pain and bleeding by maintaining pressure over the donor site and preventing food contact. The stent is worn continuously for the first 48–72 hours, then intermittently for 1–2 weeks. Without the stent, post-operative palatal haemorrhage and pain are significantly higher.
- Tooth extraction is frequently the most appropriate and evidence-based treatment for Stage IV periodontitis with poor prognosis teeth: The temptation to attempt heroic regenerative surgery on teeth with combined furcation Class III involvement, vertical bone loss to the apex, and mobile Class 3 mobility must be balanced against the evidence that such teeth have a poor long-term prognosis regardless of the regenerative intervention employed, and that maintaining them may compromise the adjacent teeth and the prosthetic plan. A strategic extraction followed by implant placement or bridge planning may produce superior long-term outcomes compared with repeated surgical attempts to maintain a tooth with a hopeless prognosis. The “hopeless” vs. “compromised” vs. “good” prognosis classification (McGuire and Nunn 1996; Kwok and Caton 2007) guides this decision — teeth classified as hopeless (vertical bone loss to or near the apex; Class III furcation in most situations; mobility Class 3 with bone loss) are most appropriately offered extraction with discussion of replacement options.
- The combination of GTR + bone graft (combined approach) produces superior outcomes to either alone for deep contained defects: For intrabony defects with ≥3 walls and ≥3 mm vertical depth, the combined approach of a resorbable collagen membrane (Bio-Gide) + xenograft bone substitute (Bio-Oss) has the most consistent evidence base in contemporary periodontal regenerative surgery. The bone graft serves as a space maintainer (preventing membrane collapse — the primary cause of GTR failure in non-titanium-reinforced membranes) while also providing an osteoconductive scaffold for new bone ingrowth. The membrane protects the graft from epithelial ingrowth and maintains the regenerative space. Multiple systematic reviews and long-term clinical studies confirm superior bone fill and CAL gain with the combined approach vs. membrane alone or graft alone for deep ≥3-wall defects. The 2019 EFP S3-level guidelines recommend the combined approach as the standard of care for contained deep infrabony defects.
Common Mistakes & Misconceptions
- Misconception: “Surgery should be performed at initial presentation for Stage III/IV periodontitis — there is no time to wait for NSPT.”
Correction: Surgery as a first-line treatment for any stage of periodontitis — including Stage IV — is incorrect. NSPT must be completed and re-evaluated before any surgical decision. Surgery performed through inflamed tissue produces poor outcomes; the response of the tissues to NSPT defines how much bone, attachment, and tissue architecture will be present at the time of surgery; and many Stage III patients achieve adequate control with NSPT alone and never require surgery. The rush to surgery denies the patient the benefits of NSPT and exposes them to unnecessary surgical risk. - Misconception: “GTR always produces complete regeneration of the lost attachment.”
Correction: GTR produces partial regeneration in most cases — a mean of approximately 1.5–2 mm additional CAL gain compared with flap debridement alone in optimal defects (Cochrane 2002). Complete regeneration of all lost attachment is not achieved reliably in any current technique. The degree of regeneration is highly defect-dependent: three-walled, deep (≥5 mm), narrow, contained defects have the best regenerative potential; two-walled defects have intermediate potential; one-walled and crateriform defects have the poorest. Setting patient expectations appropriately — explaining that surgery aims to gain additional attachment and slow disease progression, not to restore the tooth to its original state — is an ethical and clinical obligation. - Misconception: “Root coverage surgery for aesthetic recession correction can be planned without radiographic bone assessment.”
Correction: Radiographic assessment is essential before root coverage surgery to determine whether the recession is purely a soft tissue issue (no bone loss — Miller Class I/II) or is accompanied by interdental bone loss (Miller Class III/IV). Attempting root coverage on a Miller Class III recession without warning the patient that complete coverage is unlikely — and without identifying the factor (interdental bone loss) that limits the outcome — represents an inadequate assessment and an inadequate consent process. Pre-surgical periapical radiographs and interdental probing are mandatory to classify the defect correctly. - Misconception: “More bone graft is always better — packing the defect as densely as possible improves outcomes.”
Correction: Over-packing a bone graft — filling the defect so densely that the graft particles are under pressure and the overlying membrane is tented excessively — risks: (1) membrane perforation from over-fill; (2) graft particle migration through a perforated membrane into the soft tissues; (3) flap closure under tension (from excessive volume) producing dehiscence; and (4) impaired revascularisation through a densely packed graft. The graft fill should be slightly under-filled (allowing the membrane to be placed over the graft without tension) and the graft particles should be placed loosely enough to allow blood vessel ingrowth between them. Adequate graft density without over-packing is the operative principle. - Misconception: “Gingivectomy alone is sufficient for crown lengthening for restorative purposes.”
Correction: Gingivectomy alone is appropriate only for aesthetic crown lengthening where the bone is already at a correct position relative to the CEJ. For functional (restorative) crown lengthening — where the purpose is to provide sufficient tooth structure above the bone crest for margin placement without STA violation — osseous surgery is always required in addition to soft tissue resection. Without apical repositioning of the bone crest, the soft tissue will re-establish the STA through creeping reattachment within 3–6 months, and the restorative margin will again be in STA violation. This mistake leads to chronic periapical inflammation, bone loss, and repeated crown lengthening requirements — a predictable cycle of iatrogenic harm.
Related Topics
References & Sources
- Murphy KG, Gunsolley JC (2003). Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review. Annals of Periodontology, 8(1):266–302. [Cochrane-equivalent systematic review of GTR evidence — CAL gain and bone fill vs. flap debridement alone]
- Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV (2009). Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database of Systematic Reviews, Issue 4. [EMD vs. placebo and vs. GTR — additional ~1.1 mm CAL gain]
- Chambrone L, Sukekava F, Araújo MG, et al. (2010). Root-coverage procedures for the treatment of localised recession-type defects: A Cochrane systematic review. Journal of Periodontology, 81(4):452–478. [CTG + CAF gold standard for root coverage; Miller classification predictability]
- Langer B, Langer L (1985). Subepithelial connective tissue graft technique for root coverage. Journal of Periodontology, 56(12):715–720. [Original description of SCTG technique]
- Lindhe J, Westfelt E, Nyman S, Socransky SS, Heijl L, Bratthall G (1982). Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. Journal of Clinical Periodontology, 9(2):115–128. [Classic comparison of surgical vs. NSPT outcomes by initial pocket depth — surgical superior for pockets ≥7 mm]
- Tonetti MS, Cortellini P, Lang NP, et al. (2004). Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material: A randomized controlled clinical trial. Journal of Clinical Periodontology, 31(9):770–776. [Combined GTR + bone graft vs. either alone — combined approach superior]
- Sanz M, Simion M (2014). Surgical techniques on periodontal plastic surgery and soft tissue regeneration. Journal of Clinical Periodontology, 41(Suppl 15):S92–S102. [Contemporary mucogingival surgery — CAF, CTG, tunnel, MCAT techniques]
- Axelsson P, Lindhe J (1981). Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. Results after 6 years. Journal of Clinical Periodontology, 8(3):239–248. [Landmark SPT evidence — disease recurrence without maintenance; long-term stability with regular professional care]
Summary
Surgical periodontal treatment is Phase III of the four-phase treatment sequence — performed only after NSPT has been completed and re-evaluated, in compliant patients with controlled risk factors, where disease cannot be controlled non-surgically. Resective surgery (osseous surgery, gingivectomy, apically repositioned flap) eliminates pockets by removing tissue volume — appropriate for horizontal bone loss and suprabony pockets; achieves pocket elimination with permanent recession. Regenerative surgery (GTR, bone grafts, EMD) rebuilds lost attachment in contained infrabony defects — three-walled defects have best regenerative potential; GTR excludes epithelium from the root surface using a membrane barrier (resorbable collagen or non-resorbable PTFE); EMD mimics embryonic root development conditions; combined GTR + Bio-Oss + Bio-Gide is the evidence-based standard for deep ≥3-wall defects. Mucogingival surgery: SCTG + CAF is the gold standard for Miller Class I/II root coverage; FGG for keratinised tissue augmentation; Miller Class I/II → complete coverage achievable; Class III/IV → partial coverage only. Crown lengthening: functional → ARF + ostectomy mandatory (gingivectomy alone causes recurrence); aesthetic → gingivectomy only if bone at correct position. SPT (every 3–6 months, risk-stratified) is the non-negotiable Phase IV that maintains all surgical outcomes long-term — without SPT, periodontitis recurs within 2–3 years in the majority of treated patients.
Key Takeaways
- Surgery vs. NSPT by pocket depth: <3 mm → NSPT (surgery causes net attachment loss); 4–6 mm → equivalent; ≥7 mm → surgery produces significantly greater PPD reduction and CAL gain. Never do surgery before NSPT re-evaluation.
- GTR biology: Melcher (1976) — cell type determines tissue type. Membrane excludes epithelium/connective tissue; allows PDL progenitors to repopulate root surface. Resorbable (Bio-Gide, collagen) for most intrabony defects; non-resorbable (e-PTFE) for large defects requiring rigid space maintenance. Tension-free primary closure = non-negotiable.
- Bone graft hierarchy: Osteogenic + Inductive + Conductive = autograft (gold standard, donor site morbidity). Inductive + Conductive = DFDBA. Conductive only = FDBA, xenograft (Bio-Oss, most used), alloplast. Combined Bio-Oss + Bio-Gide = contemporary standard for contained defects.
- Root coverage: Miller I/II → complete coverage predictable with SCTG + CAF (gold standard). Miller III → partial only. Miller IV → unpredictable. FGG = keratinised tissue augmentation (not root coverage — poor colour match). Cairo RT1 = Miller I/II; RT2/RT3 = Miller III/IV.
- Crown lengthening: Functional (restorative) → ALWAYS ARF + ostectomy (not gingivectomy alone — recurs in 3–6 months). Aesthetic (delayed passive eruption) → gingivectomy only if bone is at correct level; + ostectomy if bone is also coronal. Measure bone to margin pre-op: need ≥3 mm tooth above bone post-op.
About the Author
